Clinical Utility of Urinary Liver‐Type Fatty Acid‐Binding Protein Measured via Point‐of‐Care Testing in Acute Kidney Injury After Transcatheter Aortic Valve Implantation

Key Result

Urinary L-FABP levels measured via point-of-care testing were independently associated with the development of acute kidney injury following transcatheter aortic valve implantation.

Key Points

• To evaluate the association between urinary l-fabp levels and acute kidney injury following transcatheter aortic valve implantation.
• Measured urinary l-fabp using point-of-care testing (POCT)
• Monitored patients after transcatheter aortic valve implantation (TAVI) for acute kidney injury development
• Conducted statistical analysis to assess the relationship between l-fabp levels and AKI
• Urinary l-fabp levels were independently associated with the development of acute kidney injury
• Elevated l-fabp levels could serve as a marker for early risk assessment in patients after TAVI